Numerous steps are necessary before initiating a clinical study at a trial site, ranging from feasibilities screening, site selection, conclusion of contracts and organisation of payment transactions till recruitment may actually start.
The OKIDS network centre centrally coordinates the necessary steps and service at OKIDS locations throughout Austria in particular for industry studies enrolling young patients.
The OKIDS national hub is also an expert partner and service provider for the successful conduct of academic studies in children and adolescents.
Medicinal products approved for adults may have different effects in children. It is necessary to test medicinal products specifically for various age ranges of childhood and adolescent in order to determine respective doses, effects and adverse reactions. Only in this way is it possible to ensure the efficacy and safety of medicinal products for these young patients.
Children and adolescents who participate in clinical studies have earlier access to new treatments.
They are under special medical observation and care during the course of the study, which is why children are usually treated more safely in studies than outside them.
OKIDS is an expert partner and service provider at five locations specialising in children and adolescents of the Medical Universities in Vienna, Linz, Innsbruck, Graz and Salzburg, as well as at the St. Anna Children’s Hospital in Vienna.
On an international level we are part of the following networks: